These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11109047)
21. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk]. von Schoultz B Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143 [No Abstract] [Full Text] [Related]
22. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277 [TBL] [Abstract][Full Text] [Related]
23. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
24. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329 [TBL] [Abstract][Full Text] [Related]
25. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414 [TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L; Dell'Aniello S; Assouline S; Suissa S BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598 [TBL] [Abstract][Full Text] [Related]
27. Risk of breast cancer in post-menopausal women using hormone replacement therapy. Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389 [TBL] [Abstract][Full Text] [Related]
28. Breast cancer and HRT--what are the data? Bieber EJ; Barnes RB Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658 [TBL] [Abstract][Full Text] [Related]
29. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477 [TBL] [Abstract][Full Text] [Related]
30. Type and duration of exogenous hormone use affects breast cancer histology. Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262 [TBL] [Abstract][Full Text] [Related]
31. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
32. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase. Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770 [TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hormone therapy and the risk of venous thromboembolism. Rachoń D; Teede H Climacteric; 2008 Aug; 11(4):273-9. PubMed ID: 18645692 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340 [TBL] [Abstract][Full Text] [Related]
35. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758 [TBL] [Abstract][Full Text] [Related]
36. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study. Dew JE; Wren BG; Eden JA Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110 [TBL] [Abstract][Full Text] [Related]
37. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC; Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103 [TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk. Col NF; Chlebowski RT Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602 [TBL] [Abstract][Full Text] [Related]
39. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA; J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216 [TBL] [Abstract][Full Text] [Related]